Screening for Breast Cancer in Men Has Increased Over Time
Risk higher for older age, Ashkenazi descent, genetic mutations, and personal, first-degree family hx.
Breast Cancer
USPSTF Expands Criteria for Recommended BRCA-Associated Genetic Counseling
A closer look at the USPSTF’s recent update to its recommendations for risk assessment, genetic counseling, and genetic testing for BRCA1/2-related cancers.
FDA Warns of Possible Interstitial Lung Disease, Pneumonitis With Certain Breast Cancer Drugs
Healthcare professionals are being advised to monitor patients regularly for pulmonary symptoms indicative of ILD and/or pneumonitis, including hypoxia, cough, dyspnea, and interstitial infiltrates on radiologic exams.
Mammography May Not Benefit Elderly Women With Chronic Illness
Risk for death from other causes much higher than risk for breast cancer death with increasing comorbidity, age.
USPSTF Advises Meds to Reduce Risk for Primary Breast Cancer
Offer risk-reducing meds to women at higher risk for breast cancer, low risk for adverse medication effects.
Germline Testing Should Be Routinely Conducted in Patients With Metastatic Breast Cancer
High prevalence of pathogenic/likely pathogenic variants supports wider testing.
Mammographic Density Parameters and Breast Cancer Tumor Characteristics Among Postmenopausal Women
[Breast Cancer: Targets and Therapy] A population-based case-control study explored whether the association between mammographic density as a risk factor for breast cancer differs across breast cancer tumor subtypes.
Analysis of Cardiovascular Disease Risks With Different Types of Cancer
Population-based cohort study demonstrated associations between many site-specific cancers and the development of CVDs.
Germline BRCA2 Mutations Linked to Pediatric Lymphomas
Survivors of NHL should be offered genetic counseling.
FDA: Men Should Be Included in Breast Cancer Clinical Trials
Draft guidance that men be included in breast cancer trials issued by the FDA.
Next post in Breast Cancer
